McKesson (NYSE: MCK)
McKesson Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
McKesson Company Info
McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. It operates through the following segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products, provides practice management, technology, clinical support, and business solutions to community-based oncology, and other specialty practices, and sells financial, operational, and clinical solutions to pharmacies and provides consulting, outsourcing, technological, and other services. The International segment provides distribution and services to wholesale, institutional, and retail customers in European countries and Canada. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The RxTS segment brings together CoverMyMeds, RelayHealth, RxCrossroads, and McKesson Prescription Automation, including Multi-Client Central Fill as a Service, to serve biopharma and life sciences partners and patients. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.
News & Analysis
McKesson Surpasses Earnings Forecast
McKesson's earnings for its fiscal 2025 second quarter exceeded expectations, despite special charges that cut into net income.
McKesson: EPS Soars, Revenue Misses
McKesson delivered mixed results in its most recent earnings release, with an EPS beat but a revenue miss.
This 1 Surprising New Tailwind Is Lifting These 2 Evergreen Stocks
New growth drivers are helping to propel these reliable and steady businesses.
2 Best Buffett Stocks to Buy for the Long Haul
Warren Buffett is selective when it comes to healthcare stocks.
If You Invested $20,000 in McKesson in 2018, This Is How Much You Would Have Today
You may not have expected the healthcare stock to beat the market, but it has -- and easily, too.
Warren Buffett Has Nearly $1 Billion in This Healthcare Stock: Should You Buy It?
This company is the largest player in the medical distribution industry and is featured in Berkshire Hathaway's investment portfolio.
Could McKesson Stock Help You Become a Millionaire?
McKesson shares aren't far from their record high.
2 Sustainable Growth Stocks to Buy Now for Long-Term Profits
Slow and sustainable growth doesn't stop them from being great investments.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.